Common blood pressure drug helps more stroke survivors reach critical health target
The REDUCE trial found spironolactone lowered blood pressure by nearly eight points in stroke survivors, but key questions about prevention remain.

TL;DR
- A new study, the REDUCE trial, explored adding spironolactone to post-stroke care to lower blood pressure.
- Participants taking spironolactone experienced an average blood pressure drop of nearly eight points after three months compared to usual care.
- More patients on spironolactone reached the recommended blood pressure goal (less than 130/80) than those on usual care (52% vs. 30%).
- Spironolactone helps the body eliminate excess salt and water, lowering blood pressure.
- Potential side effects include high potassium levels and dizziness.
- The study ended early and was not designed to prove stroke or heart attack prevention.
- Larger and longer studies are needed to determine if spironolactone prevents future strokes or heart attacks.